Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
cancer
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
avapritinib
blueprint medicines
boston
clinical trials
eli lilly
europe blog main
europe top stories
fda
genentech
indiana blog main
indiana top stories
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
roche
selpercatinib
thyroid cancer
arena pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer drugs
capmatinib
cardiovascular disease
colorectal cancer
cstone pharmaceuticals
deals
detroit blog main
detroit top stories
eisai
european medicines agency
extreme
What
cancer
4
×
fda
4
×
drug
approval
blueprint
marketing
medicines
ret
address
age
approved
approves
candidate
carries
certain
currently
designed
eisai
finally
flags
genetic
higher
huge
implications
incidence
killing
latest
lorcaserin
loss
market
medicine
modest
muscle
pact
pass
patients
post
pulls
regulatory
review
Language
unset
Current search:
biotech
×
fda
×
cancer
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@extremetech.com
8 years ago
First cancer-killing virus finally approved by FDA
